2025
Xenin-Derived Peptides: Multifaceted Regulators and Therapeutic Innovations in Metabolic Diseases
Engineered xenin peptides last longer in the body (from minutes to hours) and work better in animal diabetes models through improved insulin release and blood sugar control. Combinations of xenin with other digestive hormones show promising synergistic effects (working better together), though human clinical trials are still needed to confirm safety and effectiveness for treating metabolic diseases (conditions that disrupt how the body handles energy and sugar).
Gong B, et al.